Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Insurance plans may stop covering GLP-1s for weight loss due to cost, generic availability, or changes in eligibility criteria
A GLP-1 receptor agonist, Semaglutide has emerged as a transformative therapy for Type 2 diabetes and weight management, driven by strong outcomes in glycemic control and weight reduction, it said
Mounjaro is an injection applied once a week that has been proven to be effective in helping lower blood sugar levels and reduce body weight effectively
Yes, although both commonly cause nausea or digestive discomfort, some people tolerate one medication better than the other.
At The Blend Institute, we understand that each individual's weight loss journey is unique, which is why we offer personalized solutions tailored to your metabolic and personal needs
Your body is adjusting to the medication, and the provider wants to see how you tolerate it before increasing